AR099612A1 - Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona - Google Patents

Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona

Info

Publication number
AR099612A1
AR099612A1 ARP150100626A ARP150100626A AR099612A1 AR 099612 A1 AR099612 A1 AR 099612A1 AR P150100626 A ARP150100626 A AR P150100626A AR P150100626 A ARP150100626 A AR P150100626A AR 099612 A1 AR099612 A1 AR 099612A1
Authority
AR
Argentina
Prior art keywords
cycloprop
hydroxymethyl
hydroxy
alkyl
methyl
Prior art date
Application number
ARP150100626A
Other languages
English (en)
Spanish (es)
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of AR099612A1 publication Critical patent/AR099612A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41881,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ARP150100626A 2014-03-04 2015-03-02 Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona AR099612A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14157636 2014-03-04

Publications (1)

Publication Number Publication Date
AR099612A1 true AR099612A1 (es) 2016-08-03

Family

ID=50189621

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150100626A AR099612A1 (es) 2014-03-04 2015-03-02 Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona

Country Status (31)

Country Link
US (1) US10106544B2 (OSRAM)
EP (1) EP3114126B1 (OSRAM)
JP (1) JP6516370B2 (OSRAM)
KR (1) KR20160127127A (OSRAM)
CN (1) CN106061977B (OSRAM)
AR (1) AR099612A1 (OSRAM)
AU (1) AU2015226250B2 (OSRAM)
BR (1) BR112016020278A8 (OSRAM)
CA (1) CA2938383A1 (OSRAM)
CL (1) CL2016002207A1 (OSRAM)
CY (1) CY1121362T1 (OSRAM)
DK (1) DK3114126T3 (OSRAM)
EA (1) EA030708B1 (OSRAM)
ES (1) ES2709382T3 (OSRAM)
HR (1) HRP20190013T1 (OSRAM)
HU (1) HUE042371T2 (OSRAM)
IL (1) IL247544A0 (OSRAM)
LT (1) LT3114126T (OSRAM)
MA (1) MA39707B1 (OSRAM)
MX (1) MX2016011380A (OSRAM)
PH (1) PH12016501699A1 (OSRAM)
PL (1) PL3114126T3 (OSRAM)
PT (1) PT3114126T (OSRAM)
SA (1) SA516371717B1 (OSRAM)
SG (1) SG11201607304WA (OSRAM)
SI (1) SI3114126T1 (OSRAM)
TR (1) TR201900393T4 (OSRAM)
TW (1) TW201542556A (OSRAM)
UA (1) UA118868C2 (OSRAM)
WO (1) WO2015132228A1 (OSRAM)
ZA (1) ZA201606794B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR097617A1 (es) 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
MA39189A1 (fr) 2013-12-19 2017-06-30 Actelion Pharmaceuticals Ltd Dérivés de 1h-indazole et de 1h-indole antibactériens
AU2015261540A1 (en) 2014-05-16 2017-01-12 Idorsia Pharmaceuticals Ltd Antibacterial quinazoline-4(3h)-one derivatives
AR105646A1 (es) * 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
JP2018531902A (ja) * 2015-08-28 2018-11-01 イドーシア ファーマシューティカルズ リミテッドIdorsia Pharmaceuticals Ltd 抗菌性縮合ピロリジン−2−オン誘導体
AR105848A1 (es) * 2015-08-31 2017-11-15 Actelion Pharmaceuticals Ltd Derivados heterocíclicos antibacterianos
AR105889A1 (es) * 2015-09-03 2017-11-22 Actelion Pharmaceuticals Ltd Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
TW201840569A (zh) 2017-03-01 2018-11-16 瑞士商愛杜西亞製藥有限公司 (2r)-n-羥基-4-(6-((1-(2-羥基乙基)氮雜環丁烷-3-基)丁-1,3-二炔-1-基)-3-氧基-1h-吡咯并[1,2-c]咪唑-2(3h)-基)-2-甲基-2-(甲磺醯基)丁醯胺之結晶形式
WO2019038362A1 (en) 2017-08-24 2019-02-28 Idorsia Pharmaceuticals Ltd ANTIBACTERIAL PYRROLOIMIDAZOLONES
WO2019086452A1 (en) 2017-10-31 2019-05-09 Idorsia Pharmaceuticals Ltd Antibacterial heteroaromatic compounds
US20240382465A1 (en) * 2021-08-05 2024-11-21 Zhejiang Hisun Pharmaceutical Co., Ltd. Aromatic acetylene derivative, and preparation method therefor and use thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI338685B (en) 2002-03-13 2011-03-11 Array Biopharma Inc N3 alkylated benzimid azole derivatives as mek inhibitors
US7781591B2 (en) 2006-06-13 2010-08-24 Wyeth Llc Substituted 3-cyanopyridines as protein kinase inhibitors
DE102004017930A1 (de) 2004-04-14 2005-11-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
CA2590115A1 (en) 2004-12-10 2006-06-15 Emory University 2' and 3' - substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation
JP2008001635A (ja) 2006-06-22 2008-01-10 Toray Ind Inc グリシン誘導体及びその用途
DE102008044132A1 (de) 2008-11-27 2010-06-02 BSH Bosch und Siemens Hausgeräte GmbH Kältegerät mit zweiseitig anschlagbarer Tür
CA2758144C (en) 2009-04-06 2014-05-13 Daiichi Sankyo Company, Limited Cyclic compound having substituted phenyl group
US8372807B2 (en) 2009-05-20 2013-02-12 Ardea Biosciences, Inc. Methods of modulating uric acid levels
EP2451790A4 (en) 2009-07-07 2012-12-26 Anthem Biosciences Private Ltd INHIBITORS OF HISTONE DEACETYLASE
JP5671545B2 (ja) * 2009-10-13 2015-02-18 ファイザー・インク 抗菌薬として有用なc結合ヒドロキサム酸誘導体
CA2782453C (en) 2009-12-16 2015-11-24 Matthew Frank Brown N-linked hydroxamic acid derivatives useful as antibacterial agents
KR20140023869A (ko) 2010-11-10 2014-02-27 아카오젠, 인코포레이티드 하이드록삼산 유도체 및 세균 감염 치료에서의 이들의 사용
WO2012093809A2 (en) 2011-01-03 2012-07-12 Hanmi Pharm Co., Ltd. New bicyclic compound for modulating g protein-coupled receptors
PH12013501780A1 (en) * 2011-03-07 2019-07-03 Pfizer Fluoro-pyridinone derivatives useful as antibacterial agents
SG193367A1 (en) * 2011-04-08 2013-10-30 Pfizer Isoxazole derivatives useful as antibacterial agents
KR20130140164A (ko) * 2011-04-08 2013-12-23 화이자 인코포레이티드 항박테리아제로서 유용한 이미다졸, 피라졸 및 트라이아졸 유도체
US8859559B2 (en) 2011-12-20 2014-10-14 Boehringer Ingelheim International Gmbh Substituted pyrazines and their use in the treatment of disease
WO2013170030A1 (en) 2012-05-09 2013-11-14 Achaogen, Inc. Antibacterial agents
EP2847168A1 (en) 2012-05-10 2015-03-18 Achaogen, Inc. Antibacterial agents
WO2014165075A1 (en) 2013-03-12 2014-10-09 Achaogen, Inc. Antibacterial agents
AR097617A1 (es) 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
MA39189A1 (fr) 2013-12-19 2017-06-30 Actelion Pharmaceuticals Ltd Dérivés de 1h-indazole et de 1h-indole antibactériens
AU2015261540A1 (en) 2014-05-16 2017-01-12 Idorsia Pharmaceuticals Ltd Antibacterial quinazoline-4(3h)-one derivatives
AR105646A1 (es) 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
JP2018531902A (ja) 2015-08-28 2018-11-01 イドーシア ファーマシューティカルズ リミテッドIdorsia Pharmaceuticals Ltd 抗菌性縮合ピロリジン−2−オン誘導体
AR105848A1 (es) 2015-08-31 2017-11-15 Actelion Pharmaceuticals Ltd Derivados heterocíclicos antibacterianos
AR105889A1 (es) 2015-09-03 2017-11-22 Actelion Pharmaceuticals Ltd Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
JP2019501896A (ja) 2015-12-08 2019-01-24 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited 抗菌化合物としての置換ベンザジノン

Also Published As

Publication number Publication date
HRP20190013T1 (hr) 2019-02-22
LT3114126T (lt) 2018-12-27
MX2016011380A (es) 2016-12-07
IL247544A0 (en) 2016-11-30
US10106544B2 (en) 2018-10-23
KR20160127127A (ko) 2016-11-02
BR112016020278A8 (pt) 2017-12-26
CY1121362T1 (el) 2020-05-29
TW201542556A (zh) 2015-11-16
SI3114126T1 (sl) 2019-01-31
EP3114126B1 (en) 2018-10-31
EA030708B1 (ru) 2018-09-28
UA118868C2 (uk) 2019-03-25
DK3114126T3 (en) 2019-02-25
PT3114126T (pt) 2019-02-06
PH12016501699A1 (en) 2016-10-03
SG11201607304WA (en) 2016-09-29
HUE042371T2 (hu) 2019-06-28
AU2015226250B2 (en) 2018-12-13
CL2016002207A1 (es) 2017-03-24
SA516371717B1 (ar) 2018-10-25
CA2938383A1 (en) 2015-09-11
BR112016020278A2 (OSRAM) 2017-08-15
MA39707A (fr) 2017-01-11
WO2015132228A1 (en) 2015-09-11
JP2017508746A (ja) 2017-03-30
EA201691775A1 (ru) 2017-03-31
TR201900393T4 (tr) 2019-02-21
ES2709382T3 (es) 2019-04-16
CN106061977A (zh) 2016-10-26
US20170107223A1 (en) 2017-04-20
AU2015226250A1 (en) 2016-10-20
MA39707B1 (fr) 2019-01-31
PL3114126T3 (pl) 2019-03-29
CN106061977B (zh) 2018-10-26
JP6516370B2 (ja) 2019-05-22
EP3114126A1 (en) 2017-01-11
ZA201606794B (en) 2018-11-28

Similar Documents

Publication Publication Date Title
AR099612A1 (es) Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
AR100032A1 (es) Derivados antibacterianos de 1h-indazol y 1h-indol
AR097617A1 (es) Derivados antibacterianos del 2h-indazol
AR100428A1 (es) Derivados antibacterianos quinazolina-4(3h)-ona
AR100033A1 (es) Compuestos y composiciones para inhibir la actividad de shp2
AR093515A1 (es) Triazolopirazinas
ES2663676T3 (es) Polímeros terminados en carbinol, que contienen amina
UY38270A (es) Compuestos
MX389921B (es) Herbicidas de piperidinona.
MX380394B (es) Compuesto novedoso de bifenilo o una sal del mismo.
AR094309A1 (es) Compuesto heterociclico fusionado y uso del mismo para el control de plagas
BR112017006253A2 (pt) novos compostos
AR099177A1 (es) Determinadas (2s)-n-[(1s)-1-ciano-2-feniletil]-1,4-oxazepan-2-carboxamidas como inhibidores de dipeptidil peptidasa 1
AR093767A1 (es) Compuestos de bis(fluoroalquil)-1,4-benzodiazepinona y profarmacos de estos
AR101815A1 (es) Compuestos y composiciones como inhibidores de quinasa
AR079662A1 (es) Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa
AR118706A2 (es) Compuesto para el control de plagas y vegetación no deseada, procedimiento para prepararlo, composición que lo comprende, y compuesto intermediario relacionado
MX2022011736A (es) Pesticidas de tipo pirazol biciclico.
EA201690879A1 (ru) Новое триазолопиридиновое соединение
AR107877A1 (es) Sulfonilamidas sustituidas para combatir parásitos animales
MX2017016030A (es) Derivado de dihidropirrolopirazol sustituido.
AR097253A1 (es) Derivado de pirazolilpirazol sustituido y el uso del mismo como herbicida
AR103414A1 (es) Derivados de hidroxialquil-piperazina como moduladores del receptor cxcr3
MX2022002362A (es) Derivado de 2-aminoquinazolinona.
AR102687A1 (es) Derivados de benzotiazol antibacterianos

Legal Events

Date Code Title Description
FB Suspension of granting procedure